Neurocrine Biosciences to Present at the 23rd Annual JPMorgan Healthcare Conference
SAN DIEGO, Jan 10, 2005 /PRNewswire-FirstCall via COMTEX/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the JPMorgan Healthcare Conference in San Francisco at the Westin St. Francis Hotel, Wednesday morning, January 12, 2005 at 10:30AM Pacific Standard Time and 1:30PM Eastern Standard Time. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com or via JPMorgan's website at http://equityconferences.jpmorgan.com.
Gary Lyons, President and CEO of Neurocrine will provide an update on the Company's broad development pipeline and research programs. If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or Elizabeth Foster.
Upon connecting to the website link, select the 23rd Annual JP Morgan Healthcare Conference where you will be prompted to register for the webcast. After registering, click on the menu "Live Webcast" on the left side of the page, then select the company name Neurocrine to view the live presentation. A replay of the webcast will be available approximately 24 hours after the presentation concludes and will be archived until Wednesday, January 26, 2005. Viewers are encouraged to visit either website approximately 5 minutes prior to the presentation to download or install any necessary software.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
Investors, Claudia Jones or Elizabeth Foster, both of Neurocrine Biosciences, +1-858-617-7600
http://www.prnewswire.com